Kymera extends growth with $2.1B Sanofi deal By: Boston Business Journal via Business Journals July 09, 2020 at 07:00 AM EDT French drug giant Sanofi has evolved from one of Kymera Therapeutics Inc.’s investors to a development partner. Read More >>
